RUSSIAN EXPERIENCE WITH TAXOTERE USED IN THERAPY FOR METASTATIC HORMONE REFRACTORY PROSTATE CANCER: RESULTS OF THE DESCRIPTIVE TANDEM STUDYA

RUSSIAN EXPERIENCE WITH TAXOTERE USED IN THERAPY FOR METASTATIC HORMONE REFRACTORY PROSTATE CANCER: RESULTS OF THE DESCRIPTIVE TANDEM STUDYA

Show other versions (1)

The TANDEM multicenter open-label prospective postregistration study was initiated in 2007 to describe the Russian experience with Taxotere used to treat hormone refractory prostate cancer (HRPC) in routine practice. It enrolled a total of 149 patients; therapeutic effectiveness was analyzed in 135...

Full description

Bibliographic Details
Main Authors: O. B. Karyakin, B. Ya. Alekseyev, V. B. Matveev, A. V. Vorobyev, A. K. Nosov, A. N. Shevchenko, O. N. Burdayeva, N. A. Polyakova
Format: Article
Language:Russian
Published: ABV-press 2014-08-01
Series:Onkourologiâ
Subjects:
hormone refractory prostate cancer
chemotherapy
Taxotere
Online Access:http://oncourology.abvpress.ru/index.php/oncur/article/view/357

Similar Items

Similar Items